πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 102 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10065934

Substituted urea derivatives and pharmaceutical uses thereof

SUNSHINE LAKE PHARMA CO., LTD. Β· Granted Tue Sep 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10059689

Substituted heteroaryl compounds and methods of use

SUNSHINE LAKE PHARMA CO., LTD. Β· Granted Tue Aug 28 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 23 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9974785

Aromatic heterocyclic derivatives and pharmaceutical applications thereof

SUNSHINE LAKE PHARMA CO., LTD. Β· Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9951010

Compounds as CRTH2 antagonist and uses thereof

SUNSHINE LAKE PHARMA CO., LTD. Β· Granted Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9938257

Substituted heteroaryl compounds and methods of use

SUNSHINE LAKE PHARMA CO., LTD. Β· Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9926324

Heteroaromatic compounds as PI3 kinase modulators and methods of use

SUNSHINE LAKE PHARMA CO., LTD. Β· Granted Tue Mar 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9920033

Crystalline form of a substituted quinoline compound and pharmaceutical compositions there

SUNSHINE LAKE PHARMA CO., LTD. Β· Granted Tue Mar 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9902712

Nitrogenous heterocyclic derivatives and their application in drugs

SUNSHINE LAKE PHARMA CO., LTD. Β· Granted Tue Feb 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9884859

Solid form of pyrazolopyridine compound

SUNSHINE LAKE PHARMA CO., LTD. Β· Granted Tue Feb 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9840482

Sulfonamide derivatives and pharmaceutical applications thereof

SUNSHINE LAKE PHARMA CO., LTD. Β· Granted Tue Dec 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9828373

2-amino-pyrido[2,3-D]pyrimidin-7(8H)-one derivatives as CDK inhibitors and uses thereof

SUNSHINE LAKE PHARMA CO., LTD. Β· Granted Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9802949

Fused ring compounds as hepatitis C virus inhibitors, pharmaceutical compositions and uses

SUNSHINE LAKE PHARMA CO., LTD. Β· Granted Tue Oct 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9771358

Dihydropyrimidine compounds and their application in pharmaceuticals

SUNSHINE LAKE PHARMA CO., LTD. Β· Granted Tue Sep 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9738629

Bridged ring compounds as Hepatitis C virus inhibitors, pharmaceutical compositions and us

SUNSHINE LAKE PHARMA CO., LTD. Β· Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9718841

Bicyclic pyrazolone compounds and methods of use

SUNSHINE LAKE PHARMA CO., LTD. Β· Granted Tue Aug 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9714232

Substituted piperazine compounds and methods of use thereof

SUNSHINE LAKE PHARMA CO., LTD. Β· Granted Tue Jul 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9695150

Crystalline form of a substituted quinoline compound and pharmaceutical compositions there

SUNSHINE LAKE PHARMA CO., LTD. Β· Granted Tue Jul 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9670194

Substituted aminopyrimidine compounds and methods of use

SUNSHINE LAKE PHARMA CO., LTD. Β· Granted Tue Jun 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9663498

Aromatic heterocyclic compounds and their application in pharmaceuticals

SUNSHINE LAKE PHARMA CO., LTD. Β· Granted Tue May 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9657007

Substituted aminopyrimidine compounds and methods of use

SUNSHINE LAKE PHARMA CO., LTD. Β· Granted Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9598400

Substituted quinoline compounds and methods of use

SUNSHINE LAKE PHARMA CO., LTD. Β· Granted Tue Mar 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9598401

Substituted heteroaryl compounds and methods of use thereof

SUNSHINE LAKE PHARMA CO., LTD. Β· Granted Tue Mar 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9573953

Heteroaromatic compounds as PI3 kinase modulators and methods of use

SUNSHINE LAKE PHARMA CO., LTD. Β· Granted Tue Feb 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9567300

Hexahydropentaleno derivatives, preparation method and use in medicine thereof

SUNSHINE LAKE PHARMA CO., LTD. Β· Granted Tue Feb 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted